Patent Assignment
Reel/Frame 057381/0460
Assignment of Assignor's Interest
Recorded: 2021-09-03
Pages: 2
Assignor
WALL, G. MICHAEL
Executed: 2019-02-19
Assignee
NACUITY PHARMACEUTICALS, INC.
306 W. 7TH STREET, SUITE 310, FORT WORTH, TEXAS, 76102
Covered Property
(1)
N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3' disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) for the Prevention and Treatment of Radiation Pneumonitis and Treatment of Pulmonary Function in Cystic Fibrosis